Patrick Sandoval Returns from Injury, Targets Short-Term Deal as Reclamation Project

Pitcher Patrick Sandoval, 30, is entering free agency after a challenging 2026 season with the Boston Red Sox, posting a 5.12 ERA and 1.68 WHIP in 70.1 innings. His return followed Tommy John surgery that sidelined him until mid-2025. Despite inconsistent outings, Sandoval remains a potential buy-low option for teams seeking a low-cost starting pitcher with upside, especially on a one-year contract.
Patrick Sandoval, a 30-year-old left-handed pitcher, is entering free agency after a challenging 2026 season with the Boston Red Sox, where he posted a 5.12 ERA and 1.68 WHIP across 70.1 innings in 15 appearances (13 starts). His return came after undergoing Tommy John surgery in 2024, which sidelined him until mid-2025. Though his 2026 outings were inconsistent—six of his nine poor outings saw at least two baserunners per inning—he showed flashes of promise, including a strong August 28 performance against the Yankees. His 2026 strikeout rate exceeded one per inning, and his changeup remained effective, generating a 39.7% whiff rate despite struggles with his fastball, which opponents hit at .356 with a .589 slugging percentage. Sandoval’s career-high 2.91 ERA in 2022, when he logged 148.2 innings and posted 3.7 fWAR, provides a benchmark for potential resurgence. His contract projection calls for a one-year deal with an AAV of $5–10 million, making him a low-cost reclamation project. Teams like the Colorado Rockies, Atlanta Braves, and Kansas City Royals are seen as possible landing spots due to rotation needs, particularly for left-handed starters. The Rockies may value his ability to work through rehab-like conditions, while the Braves seek depth amid pending free agent departures of Martín Pérez and Tyler Mahle. The Royals, with a struggling 25th-ranked starting staff ERA in 2026, could use a veteran arm despite Seth Lugo’s contract extension. What remains unresolved is whether Sandoval will accept a short-term deal and which team will take the risk on his recovery trajectory.
Sandoval’s return to free agency reflects a broader trend in MLB where teams seek low-cost, high-upside arms to fill rotation gaps without long-term commitment. His profile as a buy-low candidate could influence how rebuilding or competitive teams approach short-term pitching acquisitions, particularly those with injury histories. If he performs well in 2027, his value may spike—potentially leading to trades or contract extensions—but if he struggles, the financial risk remains limited due to the one-year structure. This dynamic mirrors earlier cases like Jake Arrieta’s 2015 rebound with the Orioles after injury, which led to a lucrative deal with the Cubs. Sandoval’s situation may also affect how front offices evaluate pitchers returning from Tommy John surgery, especially those with strong secondary pitches. The market for such players could tighten if multiple teams view him as a viable option. What to watch for is whether his changeup remains effective under pressure and whether he can improve his ground ball rate—key indicators of long-term viability. His success may also influence how teams approach player development and risk assessment in the coming seasons.